Raj S. Pruthi, MD, MHA, FACS
Raj S. Pruthi, MD, MHA, FACS
Dr. Pruthi became professor and chair of the UCSF Department of Urology in January, 2020, succeeding Dr. Peter R. Carroll. He previously served as chair of the Department of Urology at the University of North Carolina at Chapel Hill (UNC Chapel Hill), where he was on faculty for nineteen years.
Serving first as its chief and then as its inaugural chair, he took the UNC Department of Urology from an unranked program to one of the best in the nation. It also became the only basic science or clinical department at the UNC School of Medicine with 100% faculty satisfaction. During his tenure at UNC Chapel Hill, Dr. Pruthi built a strong, multi-million-dollar urology research operation and developed a highly-regarded residency program.
Nationally, Dr. Pruthi serves in a number of professional and academic capacities:
He was a member of the ABU/AUA Examination Committee and serves as an examiner for the Certifying Exam for the ABU. He also on the Executive Committee for the Society of Academic urology and currently serves as the organization’s treasurer. He is also the Chair of the Advisory Council for Urology of the American College of Surgeons, and also serves on the Board of Governors for the College.
He served on the Guidelines Committee and helped to develop the American Urological Associations Guidelines on the Management of Non-muscle Invasive Bladder Cancer and also served on the Bladder Cancer Guidelines Committee of the International Consultation on Urological Diseases.
He is an elected member of the Urologic Research Society, the Society of Pelvic surgeons, the American Association of Genitourinary Surgeons, and the Clinical Society of Genitourinary Surgeons.
Dr. Pruthi is a graduate of Stanford University, where he double majored in economics and in biology and became interested in health economics. He received his MD degree from the Duke University School of Medicine. Following medical school, he completed his residency and post-graduate training at Stanford University. Most recently, he completed the executive MHA program at UNC.
Dr. Pruthi’s area of clinical expertise is urologic oncology, including prostate and bladder cancer. He is committed to a multi-disciplinary, holistic, and patient-centric approach to care. He continuously explores the potential of new technologies, including novel imaging and molecular approaches, to advance early detection of disease and accurate risk assessment.
Dr. Pruthi is a recognized expert in minimally-invasive, robotic surgery for prostate and bladder cancer. He incorporates nerve-sparing techniques to improve recovery and long-term quality of life. He is focused on optimizing a patient’s surgical journey and integration of patient-reported outcomes to improve his patients’ experiences and recovery. He and collaborators study the use of health-information technology to provide early feedback so as to address preventable complications and reduce readmissions. He is committed to compassionate, comprehensive, innovative, and patient-centered care that balances long-term survivorship with a high-level of functioning and an optimal quality of life.
Dr. Pruthi’s research is focused on surgical innovation, care pathways, and quality of care. Most recently, this primary research has addressed topics related to health economics, including characterizing the urologic workforce, understanding compensation, productivity, and burnout.
His early research, reflecting his busy practice as a clinician, was centered on surgical innovation, including the earliest descriptions of robotic approaches to bladder cancer. This was followed by research on process innovation, including clinical care pathways to optimize the patient experience, an area which he perceived as needing substantial quality improvement.
Working on optimizing care pathways led him to focus on the potential of innovative health information technology, including mobile applications, to maintain post-operative contact and improve quality of care and patient safety. Along with collaborators, Dr. Pruthi’s longer-term research objectives are to develop and evaluate the effectiveness of innovative mobile health strategies that can rapidly identify and address potentially serious problems by cancer patients after surgery.
In his role as chair, Dr. Pruthi has been tackling health economic issues to better understand the drivers of faculty productivity, compensation, and burnout. He has explored urologic workforce, projections, gender disparity issues, factors impacting career earnings, predictors of dissatisfaction and burnout, and understanding the impact of workflow initiatives, including the implementation of scribes. His work in these areas has been recognized nationally and has had an impact on the understanding of the practice of urology.
1825 4th Street
6th floor Baker Precision Cancer Medicine Building
San Francisco, CA 94158
Nurse Navigator for general questions
regarding making an appointment
New Patient Coordinator
University of California, San Francisco
Department of Urology, Mailcode 1695
550 16th Street, 6th Floor
San Francisco, CA 94143